Edward M. Barnett, MD, PhD

Publications

• Single-cell resolution imaging of retinal ganglion cell apoptosis in vivo using a cell-penetrating caspase-activatable peptide probe.

  (Qiu X, Johnson JR, Wilson BS, Gammon ST, Piwnica-Worms D, Barnett EM.) PLoS One. 2014;9(2):e88855 PMID: 24586415 PMCID: PMC3931650 03/04/2014

• Optic nerve diffusion tensor imaging parameters and their correlation with optic disc topography and disease severity in adult glaucoma patients and controls.

  (Chang ST, Xu J, Trinkaus K, Pekmezci M, Arthur SN, Song SK, Barnett EM.) J Glaucoma. 2014;23(8):513-20 PMID: 23632406 PMCID: PMC3800509 05/02/2013

• Caspase-activated cell-penetrating peptides reveal temporal coupling between endosomal release and apoptosis in an RGC-5 cell model.

  (Johnson JR, Kocher B, Barnett EM, Marasa J, Piwnica-Worms D.) Bioconjug Chem. 2012 Sep 19;23(9):1783-93 PMID: 22900707 PMCID: PMC3447108 08/21/2012

• The incidence of retinal vein occlusion in the ocular hypertension treatment study.

  (Barnett EM, Fantin A, Wilson BS, Kass MA, Gordon MO, Ocular Hypertension Treatment Study Group.) Ophthalmology. 2010 Mar;117(3):484-8 PMID: 20031222 PMCID: PMC3077045 12/25/2009

• VAV2 and VAV3 as candidate disease genes for spontaneous glaucoma in mice and humans.

  (Fujikawa K, Iwata T, Inoue K, Akahori M, Kadotani H, Fukaya M, Watanabe M, Chang Q, Barnett EM, Swat W.) PLoS One. 2010 Feb 04;5(2):e9050 PMID: 20140222 PMCID: PMC2816215 02/09/2010

• Single-cell imaging of retinal ganglion cell apoptosis with a cell-penetrating, activatable peptide probe in an in vivo glaucoma model.

  (Barnett EM, Zhang X, Maxwell D, Chang Q, Piwnica-Worms D.) Proc Natl Acad Sci U S A. 2009 Jun 09;106(23):9391-6 PMID: 19458250 PMCID: PMC2695102 05/22/2009

• An improved cell-penetrating, caspase-activatable, near-infrared fluorescent peptide for apoptosis imaging.

  (Maxwell D, Chang Q, Zhang X, Barnett EM, Piwnica-Worms D.) Bioconjug Chem. 2009 Apr;20(4):702-9 PMID: 19331388 PMCID: PMC2672423 04/01/2009

• Aqueous humor sCD44 concentration and visual field loss in primary open-angle glaucoma.

  (Nolan MJ, Giovingo MC, Miller AM, Wertz RD, Ritch R, Liebmann JM, Allingham RR, Herndon LW, Wax MB, Smolyak R, Hasan F, Barnett EM, Samples JR, Knepper PA.) J Glaucoma. 2007 Aug;16(5):419-29 PMID: 17700283 08/19/2007

• Selective cell uptake of modified Tat peptide-fluorophore conjugates in rat retina in ex vivo and in vivo models.

  (Barnett EM, Elangovan B, Bullok KE, Piwnica-Worms D.) Invest Ophthalmol Vis Sci. 2006 Jun;47(6):2589-95 PMID: 16723475 05/26/2006

• Detection of the free acid of bimatoprost in aqueous humor samples from human eyes treated with bimatoprost before cataract surgery.

  (Camras CB, Toris CB, Sjoquist B, Milleson M, Thorngren JO, Hejkal TW, Patel N, Barnett EM, Smolyak R, Hasan SF, Hellman C, Meza JL, Wax MB, Stjernschantz J.) Ophthalmology. 2004 Dec;111(12):2193-8 PMID: 15582073 12/08/2004

• Cytotoxic T cell-resistant variants are selected in a virus-induced demyelinating disease.

  (Pewe L, Wu GF, Barnett EM, Castro RF, Perlman S.) Immunity. 1996 Sep;5(3):253-62 PMID: 8808680 09/01/1996

• Anterograde tracing of trigeminal afferent pathways from the murine tooth pulp to cortex using herpes simplex virus type 1.

  (Barnett EM, Evans GD, Sun N, Perlman S, Cassell MD.) J Neurosci. 1995 Apr;15(4):2972-84 PMID: 7536824 PMCID: PMC6577775 04/01/1995